🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1 study evaluating the safety of ABT-263 administered in co...
Status
Completed
Location
University of Arizona Cancer Center - North Campus /ID# 16721
Start Date
2009-07-21
Trial ID
NCT00788684
60 patients of radiological, biopsy proven advanced HCC (Hepatocellular car...
Status
Completed
Location
Institute of Liver & Biliary Sciences
Start Date
2014-10-01
Trial ID
NCT02259647
Everolimus is an oral mTOR inhibitor with demonstrated preliminary efficacy...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2009-05
Trial ID
NCT00869999
Treatments Being Tested
The purpose of this clinical trial is to evaluate efficacy and safety of ti...
Status
Recruiting
Location
Mayo Clinic Cancer Center
Start Date
2026-06-12
Trial ID
NCT07104032
Treatments Being Tested
The purpose of this study is to determine how multiple doses of canaglifloz...
Status
Completed
Location
Multiple Locations
Start Date
2008-07
Trial ID
NCT01733108
Treatments Being Tested
Monoclonal antibodies can locate tumor cells and either kill them or delive...
Status
Completed
Location
Children's Oncology Group
Start Date
2001-01
Trial ID
NCT00005576
Treatments Being Tested
The central retinal vein occlusion (CRVO) is a major cause of ocular morbid...
Status
Unknown
Location
CHNO des Quinze-Vingts
Start Date
2015-12
Trial ID
NCT02957760
Treatments Being Tested
This is a Phase 1 study evaluating the safety of ABT-263 administered in co...
Status
Completed
Location
Site Reference ID/Investigator# 17841
Start Date
2009-11
Trial ID
NCT00868413
The goal of this clinical research study is to learn if the combination of ...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2003-09
Trial ID
NCT00504660
Treatments Being Tested
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested